Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Migraine

  Free Subscription


06.06.2022

1 BMC Neurol
4 Cephalalgia
1 Neurol Genet


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. MAGDY R, Eid RA, Hassan M, Abdelghaffar M, et al
    The potential impact of nutritional intake on symptoms severity in patients with comorbid migraine and irritable bowel syndrome.
    BMC Neurol. 2022;22:199.
    PubMed         Abstract available


    Cephalalgia

  2. SUDAT SE, Jacobson AS, Avins AL, Lipton RB, et al
    A population-health approach to characterizing migraine by comorbidity: Results from the Mindfulness and Migraine Cohort Study.
    Cephalalgia. 2022 May 31:3331024221104180. doi: 10.1177/03331024221104180.
    PubMed         Abstract available

  3. CHRISTENSEN CG, Techlo TR, Kogelman LJ, Wegner Thorner L, et al
    Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria.
    Cephalalgia. 2022 May 29:3331024221094548. doi: 10.1177/03331024221094548.
    PubMed         Abstract available

  4. EVERS S, Frese A, Summ O, Husstedt IW, et al
    Levetiracetam in the prophylactic treatment of episodic migraine: A prospective open label study.
    Cephalalgia. 2022 May 27:3331024221103815. doi: 10.1177/03331024221103815.
    PubMed         Abstract available

  5. MOUAANAKI SA, Carlsen LN, Bendtsen L, Jensen RH, et al
    Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center.
    Cephalalgia. 2022 May 27:3331024221104178. doi: 10.1177/03331024221104178.
    PubMed         Abstract available


    Neurol Genet


  6. Erratum: Migraine, Stroke, and Cervical Arterial Dissection: Shared Genetics for a Triad of Brain Disorders With Vascular Involvement.
    Neurol Genet. 2022;8:e675.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: